Glaxo Genital Herpes Vaccine Flops but Genocea a Buy in Vaccine Space
Posted on January 01, 2013 at 10:29 AM EST
By Rex Graham A Glaxo Smith Kline (GSK) genital herpes vaccine recently flopped in a large clinical trial, but “next generation” genital herpes vaccines by Genocea Biosciences, Agenus, Inc. (AGEN), Vical, Inc. (VICL), and Sanofi Pasteur (SNY) offer new hope for an effective vaccine treatment. A Yale University study published in the Nov. 15, 2012, [...]